Stefan K.f. Schwabe, Executive VP R&D, CMO at SUPERNUS PHARMACEUTICALS INC (SUPN), sold 60,000 shares at $54.39 ($3.3M) on 2018-06-18, disclosed to the SEC on 2018-06-19.
Open-market sale of $3.3M SUPN by Executive VP R&D, CMO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| SUPN | SELL | 2017-09-11 | $4.4M | — | Filing → |
| SUPN | SELL | 2015-07-29 | $50K | — | Filing → |
| SUPN | SELL | 2015-07-29 | $37K | — | Filing → |